Vivos, Inc. (RDGL)
0.0453
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Vivos Debt to Equity Ratio : 0.0375 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0375 |
| March 31, 2026 | 0.0406 |
| December 31, 2025 | 0.0688 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.2077 |
| June 30, 2021 | 0.1817 |
| March 31, 2021 | 0.161 |
| December 31, 2020 | 10.76 |
| September 30, 2020 | -0.3379 |
| June 30, 2020 | -0.5015 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3943 |
| December 31, 2019 | -0.5315 |
| September 30, 2019 | -0.4973 |
| June 30, 2019 | -0.2645 |
| March 31, 2019 | -0.2297 |
| December 31, 2018 | -0.0571 |
| September 30, 2018 | -0.0796 |
| June 30, 2018 | -0.3398 |
| March 31, 2018 | -0.7045 |
| December 31, 2017 | -0.6914 |
| September 30, 2017 | -0.6613 |
| June 30, 2017 | -0.5937 |
| March 31, 2017 | -0.4544 |
| December 31, 2016 | -0.2903 |
| September 30, 2016 | -0.4243 |
| June 30, 2016 | -0.2987 |
| March 31, 2016 | -0.2131 |
| December 31, 2015 | -0.3159 |
| September 30, 2015 | -0.3894 |
| June 30, 2015 | -0.3751 |
| March 31, 2015 | -0.2571 |
| December 31, 2014 | -0.2515 |
| September 30, 2014 | -0.5243 |
| June 30, 2014 | -0.7391 |
| March 31, 2014 | -0.7575 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| IDEXX Laboratories, Inc. | 0.6797 |
| Neogen Corp. | 0.388 |
| QuidelOrtho Corp. | 1.733 |
| Aspira Women's Health, Inc. | -0.4279 |
| Biomerica, Inc. | 0.9061 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.880M |
| Total Liabilities (Quarterly) | 0.124M |
| Shareholders Equity (Quarterly) | 2.756M |
| Current Ratio | 48.82 |
| Net Debt Paydown Yield | -0.07% |